Jonathan Alicea

A new cross-sectional study uncovers shortcomings in pivotal trials supporting new drug applications for opioid analgesics, which range from study design to duration.

These recommendations were developed with the primary goal of improving outcomes in cardiovascular mortality.

Between 1999 and 2016, cardiovascular disease prevalence declined at a much faster for the highest-income earners than the rest of the population.

Educating patients of the immune system can be helpful in addressing any concerns over getting vaccinated for the flu.

A study found that patients more commonly self-reported unintentional barriers to treatment adherence—such as forgetfulness and external influences—than intentional ones.

Ketotifen fumarate ophthalmic solution 0.035% is the first and only over-the-counter preservative-free eye drop solution for itchy eyes caused by allergies.

Testing all IBD patients for CMV can lead to a concerning overconsumption of resources as well as a delay in treatment.

An expert discusses the importance of getting vaccinated for the flu this year as well as strategies healthcare systems are taking to ensure easy access for patients.

These discrepancies are more pronounced in young, adolescent females and older adolescent males.

D. farinae and D. pteronyssinus positive skin prick test results were much more frequent in patients >18 years.

This decrease in hospital admissions had no association with regional prevalence of COVID-19.

About 2/3 of children with asthma had been exposed to opioids prior to birth, according to a new retrospective study.

Gene addition and editing strategies have potential of curing sickle cell disease and transfusion-dependent thalassemia, but there are still many obstacles that must be overcome.

According to a retrospective claims database study, as many as 43.8% of assessed patients with open-angle glaucoma required a change from initial treatment.

Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.

Both antihistamines are indicated for treatment of chronic idiopathic urticaria, yet olopatadine demonstrates better clinical improvements and fewer adverse events.

Current therapies focus on relief of symptoms, but there is still an unmet need to address and target the molecular defects of hypertrophic cardiomyopathy.

The methodologies used to screen sickle cell disease are also able to detect alpha-thalassemia, which is currently not a core condition of the United States Recommended Uniform Screening Panel.

An expert discusses the difficulties in diagnosing and managing myositis, as well as how the COVID-19 pandemic has affected clinical care.

Care of rheumatic patients must factor in cradiovascular risk and conditions.

The recently published American College of Rheumatology guidelines on reproductive health is a great resource for rheumatologists.

An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.

MIS-C is a condition recently recognized in children with COVID-19.

Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.

In the MONARCH OLE study, more than 50% of patients with rheumatoid arthritis who had low or inadequate response to adalimumab and switched to sarilumab experienced an improvement in disease activity.

Patient assessments measured fatigue, disease activity, global spinal pain, and spinal pain at night.

COVID-19 is associated with its own cytokine storm syndrome.

These findings suggest the possibility of a common underlying disease process between the two pathologies.

Report shows that sarilumab may be better at controlling severe and refractory pain in rheumatoid arthritis patients than adalimumab.

An expert discusses the risks that rheumatic diseases pose for pregnancies as well as the conversations rheumatologists need to have with their patients.